Michael May

Michael May is the President and CEO of CCRM. Michael completed his BASc in Chemical Engineering at the University of Toronto in 1991. He then went on to complete his PhD in Chemical Engineering at the University of Toronto under the supervision of Michael Sefton in 1998. From 2000-2010, Michael was the President, Chief Operating Officer and Co-founder of Rimon Therapeutics Ltd., a Toronto-based regenerative medicine company developing novel medical polymers that possess drug-like activity. Michael sits on a number of Boards and advisory committees and he has coached hockey at the Rep level for over seven years.

Posts by: Michael


Special op/ed: Canada can lead the world in regenerative medicine — but it won’t happen without strategic investment

Author: Michael May, 08/30/16

Michael May is President and CEO of CCRM, a leader in developing and commercializing regenerative medicine, cell and gene therapy technologies, Michael Rudnicki is Scientific Director and CEO of Stem Cell Network, with a mandate to translate stem cell research into clinical applications, commercial products and public policy, and Peter Zandstra is a professor in…Read more

Creating an ecosystem for Canadian RM commercialization

Author: Michael May, 11/19/12

James Till and Ernest McCulloch identified stem cells 50 years ago in Toronto, and their legacy is a vibrant community of scientists who are leaders in this field of research. But what does that mean in terms of producing products and therapies to heal and cure patients? While Canada is an acknowledged leader in the…Read more